Literature DB >> 20683018

A3 adenosine receptor antagonist, truncated Thio-Cl-IB-MECA, induces apoptosis in T24 human bladder cancer cells.

Heejong Kim1, Jeong Woo Kang, Sojung Lee, Won Jun Choi, Lak Shin Jeong, Young Yang, Jin Tae Hong, Do Young Yoon.   

Abstract

BACKGROUND: Human A(3) adenosine receptor (A(3)AR) plays an essential role in several physiopathological processes. Thus far, A(3)AR-selective ligands have been evaluated as anti-inflammation and anticancer therapeutic agents. Among these ligands, truncated thio-Cl-IB-MECA is a newly reported antagonist, and its function has not been studied.
MATERIALS AND METHODS: Cell viability was measured by MTS assay. Cell cycle progression was analysed by propidium iodide (PI) flow cytometric assay. The apoptotic effects were investigated by Hoechst staining and annexin V-FITC/PI staining. The signal-transduction mechanism was explored by Western blot.
RESULTS: Truncated thio-Cl-IB-MECA induced the growth arrest of T24 cells at sub-G(1) phase and provoked apoptosis but not necrosis. Apoptotic death was mediated by the activation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK).
CONCLUSION: Since truncated thio-Cl-IB-MECA induces anti-proliferation and apoptotic effects via ERK and JNK activation, it may function as an anticancer agent in human bladder cancer cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20683018

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

Review 1.  Anticancer effect of adenosine on gastric cancer via diverse signaling pathways.

Authors:  Ayako Tsuchiya; Tomoyuki Nishizaki
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

2.  Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cells.

Authors:  Iolanda D'Alimonte; Eleonora Nargi; Mariachiara Zuccarini; Paola Lanuti; Patrizia Di Iorio; Patricia Giuliani; Lucia Ricci-Vitiani; Roberto Pallini; Francesco Caciagli; Renata Ciccarelli
Journal:  Purinergic Signal       Date:  2015-05-15       Impact factor: 3.765

Review 3.  A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.

Authors:  Kenneth A Jacobson; Stefania Merighi; Katia Varani; Pier Andrea Borea; Stefania Baraldi; Mojgan Aghazadeh Tabrizi; Romeo Romagnoli; Pier Giovanni Baraldi; Antonella Ciancetta; Dilip K Tosh; Zhan-Guo Gao; Stefania Gessi
Journal:  Med Res Rev       Date:  2017-07-06       Impact factor: 12.944

4.  Mitochondrial and caspase pathways are involved in the induction of apoptosis by IB-MECA in ovarian cancer cell lines.

Authors:  Hamideh Abedi; Mahmoud Aghaei; Mojtaba Panjehpour; Sima Hajiahmadi
Journal:  Tumour Biol       Date:  2014-08-06

5.  Functional selectivity of adenosine receptor ligands.

Authors:  Dennis Verzijl; Ad P Ijzerman
Journal:  Purinergic Signal       Date:  2011-05-05       Impact factor: 3.765

Review 6.  Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function.

Authors:  Selena Vigano; Dimitrios Alatzoglou; Melita Irving; Christine Ménétrier-Caux; Christophe Caux; Pedro Romero; George Coukos
Journal:  Front Immunol       Date:  2019-06-06       Impact factor: 7.561

7.  A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity.

Authors:  Andrea Spinaci; Michela Buccioni; Diego Dal Ben; Federica Maggi; Gabriella Marucci; Beatrice Francucci; Giorgio Santoni; Catia Lambertucci; Rosaria Volpini
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-28

Review 8.  Targeting Immunometabolism in Glioblastoma.

Authors:  Aditya A Mohan; William H Tomaszewski; Aden P Haskell-Mendoza; Kelly M Hotchkiss; Kirit Singh; Jessica L Reedy; Peter E Fecci; John H Sampson; Mustafa Khasraw
Journal:  Front Oncol       Date:  2021-06-16       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.